Enbrel and Cataflam drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Enbrel (etanercept) and Cataflam (diclofenac potassium). Common drug interactions include pruritus among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Enbrel and Cataflam. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.
What is Enbrel?
Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.
What is Cataflam?
Cataflam has active ingredients of diclofenac potassium. It is often used in pain. eHealthMe is studying from 1,851 Cataflam users. Check the latest studies of Cataflam.
56 people who take Enbrel and Cataflam together, and have interactions are studied.

What are the common drug interactions of Enbrel and Cataflam, by gender? *:
female:
- Pruritus (severe itching of the skin)
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
- Pustular psoriasis (raised bumps on the skin that are filled with pus)
- Rash macular (small, flat red spots)
- Skin discolouration (change of skin colour)
- Tooth loss
- Wound infection
- Abdominal discomfort
- Abdominal pain
- Alopecia (absence of hair from areas of the body)
male:
- Drug ineffective
- Spinal osteoarthritis (joint cartilage loss in spine)
- Pain in extremity
- Walking disability
- Diarrhoea
- Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
- Psoriasis (immune-mediated disease that affects the skin)
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
- Urinary tract infection
- Dysentery (infection of the intestines resulting in severe diarrhoea with the presence of blood and mucus in the faeces)
What are the common drug interactions of Enbrel and Cataflam, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Dermatitis allergic (inflammation of the skin due allergic reaction)
- Sensation of foreign body
20-29:
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Psoriasis (immune-mediated disease that affects the skin)
30-39:
- Brain stem infarction (brainstem stroke)
- Hypertension (high blood pressure)
- Tuberculin test positive
- Dyspnoea (difficult or laboured respiration)
- Escherichia infection (bacterial infection by escherichia coli)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Nephritis (inflammation of the nephrons in the kidneys)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Corneal infection (corneal infection)
- Meningeal disorder (disease of meninges)
40-49:
- Arthralgia (joint pain)
- Arthropathy
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Discomfort
- Ear infection
- Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
- Hepatic enzyme increased
- Hypersensitivity
- Influenza
- Injection site rash
50-59:
- Dyslipidaemia (abnormal amount of lipids)
- Spinal osteoarthritis (joint cartilage loss in spine)
- Spinal pain (pain in spine)
- Arthralgia (joint pain)
- Drug ineffective
- Fatigue (feeling of tiredness)
- Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
- Hypersensitivity
- Inflammation
- Injection site erythema (redness at injection site)
60+:
- Drug ineffective
- Arthralgia (joint pain)
- Inflammation
- Therapeutic response decreased (less preventive response)
- Activities of daily living impaired
- Asthenia (weakness)
- Decreased immune responsiveness
- Depressed mood
- Erythema (redness of the skin)
- Eye disorder
What are the existing conditions these people have? *
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 10.71%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 6 people, 10.71%
- Psoriasis (immune-mediated disease that affects the skin): 3 people, 5.36%
* Approximation only. Some reports may have incomplete information.
Do you take Enbrel and Cataflam?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Enbrel and Cataflam:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Enbrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cataflam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Enbrel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cataflam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on etanercept and diclofenac potassium (the active ingredients of Enbrel and Cataflam, respectively), and Enbrel and Cataflam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Pravastatin Sodium and Revatio - 7 seconds ago
- Could Pantoprazole cause Chest Pain? - 7 seconds ago
- Drug interactions of Genotropin and Meclizine - 17 seconds ago
- Could Klonopin cause Bradyphrenia? - 18 seconds ago
- Valerian vs. Progesterone, side effect and effectiveness comparison - 20 seconds ago
- Could Beconase Aq cause Chronic Kidney Disease? - 20 seconds ago
- Could Avastin cause Ovarian Mass? - 20 seconds ago
- Could Bactrim cause Nephropathy? - 20 seconds ago
- Could Albuterol Sulfate cause Road Traffic Accident? - 22 seconds ago
- Could Furosemide cause Anion Gap Decreased? - 24 seconds ago